research use only
Cat.No.S8383
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| human T-ALL cell lines | Cell viability assay | 72 h | Cell lines are sensitive to S63845 treatment as shown by 50% growth inhibitory (IC50) values in a submicromolar range. | 30008477 | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 100 mg/mL
(120.58 mM)
Ethanol : 38 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 829.26 | Formula | C39H37ClF4N6O6S |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1799633-27-4 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC1=C(C=CC(=C1Cl)OCCN2CCN(CC2)C)C3=C(SC4=NC=NC(=C34)OC(CC5=CC=CC=C5OCC6=CC=NN6CC(F)(F)F)C(=O)O)C7=CC=C(O7)F | ||
| Targets/IC50/Ki |
human MCL-1
0.19 nM(Kd)
|
|---|---|
| In vitro |
S63845 induces death of cancer cell lines with known reliance on MCL-1, displaying classical hallmarks of apoptosis that are dependent on caspases and BAX/BAK-mediated mitochondrial outer membrane permeabilisation. It has a 6 fold higher affinity for human MCL-1 over mouse MCL-1. This compound is effective against haematological cancer-derived cell lines in vitro and in vivo and also AML samples, but does not readily kill normal human haematopoietic progenitor cells.
|
| In vivo |
In vivo, S63845 shows potent anti-tumour activity with an acceptable safety margin as a single agent in several cancers. This compound is well tolerated by the mice with no significant weight loss observed. Some of solid tumour models shows sensitivity to this compound monotherapy, while many others are only killed when treated with a combination of this compound and inhibitors of oncogenic kinases.
|
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Immunofluorescence |